PeptidePedia The community reference

Contributions of StabilityStig

User contributions·41 logged edits·page 1 of 1

Contributions by StabilityStig, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,277 edits includes activity predating the current log.

  1. 08:33, 21 Jul 2026 (diff | hist) Talk:Beyond-use date 1,296 +170 /* Should Peptide stability table carry the defaults instead? */ reply
  2. 12:15, 17 Jul 2026 (diff | hist) Placebo-adjusted effect 4,805 ±0 split the results table so the two doses are separate rows
  3. 08:32, 19 Jun 2026 (diff | hist) Sharps disposal 17,901 +1,544 expand §Upstream prevention
  4. 22:24, 16 Jun 2026 (diff | hist) Sharps disposal 16,357 +22 m add the note about drawing air before withdrawal
  5. 09:50, 1 Jun 2026 (diff | hist) Talk:Chain of custody 674 +139 /* Storage confound */ new section
  6. 10:20, 29 May 2026 (diff | hist) Talk:Cagrilintide 537 +175 /* Aggregation and method coverage */ new section
  7. 14:15, 22 May 2026 (diff | hist) Talk:Methionine oxidation 748 +147 /* Polysorbate peroxides */ reply
  8. 13:25, 30 Apr 2026 (diff | hist) Talk:Deamidation 748 +129 /* Storage versus manufacture */ reply
  9. 11:44, 30 Apr 2026 (diff | hist) Talk:Liraglutide 537 +169 /* Heptamer self-association */ new section
  10. 10:30, 25 Apr 2026 (diff | hist) Talk:Bacteriostatic water 537 +183 /* Preservative-induced aggregation */ new section
  11. 10:15, 22 Apr 2026 (diff | hist) Talk:Cold-chain freight 537 +155 /* Robustness of the dry solid */ new section
  12. 18:59, 21 Apr 2026 (diff | hist) Karl Fischer titration 9,318 ±0 add the system-suitability criteria the method actually specifies
  13. 09:17, 16 Apr 2026 (diff | hist) Talk:Peptide stability table 1,096 +206 /* RfC: should the table give a −20 °C default for research powders? */ reply
  14. 14:20, 27 Mar 2026 (diff | hist) Talk:Reconstitution of lyophilised peptides 748 +172 /* Register: description or instruction? */ reply
  15. 08:25, 12 Mar 2026 (diff | hist) Talk:Glucagon 537 +180 /* Fibrillation paragraph belongs here or at aggregation? */ new section
  16. 09:38, 11 Mar 2026 (diff | hist) Talk:Temperature excursion 1,233 +228 /* Should freezing be a separate article? */ reply
  17. 10:17, 3 Mar 2026 (diff | hist) Dose escalation schedule 4,993 ±0 ce
  18. 09:40, 16 Feb 2026 (diff | hist) Talk:Analytical method validation 400 +201 /* Stability-indicating claims */ new section
  19. 20:14, 11 Feb 2026 (diff | hist) Active pharmaceutical ingredient 4,569 ±0 copyedit
  20. 09:40, 27 Jan 2026 (diff | hist) Talk:Amylin 674 +176 /* Species difference in aggregation */ new section
  21. 05:35, 27 Jan 2026 (diff | hist) Beyond-use date 23,171 +63 expand §Assignment in the absence of data
  22. 02:35, 20 Jan 2026 (diff | hist) HOMA-IR 4,511 ±0 add the units and the conversion factor to SI
  23. 10:20, 17 Jan 2026 (diff | hist) Talk:Peptide aggregation 400 +142 /* Reversible versus irreversible */ new section
  24. 13:53, 6 Nov 2025 (diff | hist) Multi-dose vial 22,608 +847 give the worked example to two significant figures throughout
  25. 09:59, 26 Oct 2025 (diff | hist) Growth hormone secretagogue 4,613 ±0 m ce, tighten prose
  26. 08:20, 22 Sep 2025 (diff | hist) Talk:Lyophilisation 1,307 +151 /* Collapse temperature and Tg-prime are being used interchangeably */ reply
  27. 11:07, 19 Sep 2025 (diff | hist) Talk:Lyophilisation 674 +430 /* Collapse temperature and Tg-prime are being used interchangeably */ new section
  28. 08:47, 10 Sep 2025 (diff | hist) Talk:Peptide stability table 1,033 +267 /* Sourcing of the reconstituted-stability column */ reply
  29. 11:04, 8 Sep 2025 (diff | hist) Talk:Peptide stability table 400 +499 /* Sourcing of the reconstituted-stability column */ new section
  30. 00:27, 31 Aug 2025 (diff | hist) Reconstitution of lyophilised peptides 5,761 ±0 state the number of doses a vial yields at that concentration
  31. 07:54, 16 Aug 2025 (diff | hist) Bacteriostatic water 4,652 ±0 give the worked example to two significant figures throughout
  32. 13:48, 15 Jul 2025 (diff | hist) Talk:Nantong Guangyuan Chemical 748 +224 /* The warehouse interval is a fact a purchaser can ask for */ reply
  33. 12:07, 11 Jun 2025 (diff | hist) Talk:Temperature excursion 611 +233 /* Worked MKT example: check of the arithmetic */ reply
  34. 20:14, 3 Apr 2025 (diff | hist) Area percent purity 6,569 ±0 space between number and unit per PP:MOS
  35. 09:26, 28 Mar 2025 (diff | hist) Talk:Multi-dose vial 822 +195 /* The 28-day rule is being cited as a stability figure */ reply
  36. 06:12, 12 Dec 2024 (diff | hist) Insulin syringe 3,647 ±0 m add the shelf life after first puncture, attributed
  37. 09:00, 27 Nov 2024 (diff | hist) Personal importation policy 1,572 +1,572 N create article — regulatory stub
  38. 15:31, 26 Oct 2024 (diff | hist) Dipeptidyl peptidase-4 4,012 +717 space between number and unit per PP:MOS
  39. 11:03, 28 Sep 2024 (diff | hist) Injection site rotation 2,155 ±0 m add the beyond-use interval with the storage condition it assumes
  40. 16:17, 14 Aug 2024 (diff | hist) Subcutaneous injection 2,092 ±0 m serial comma per PP:MOS
  41. 02:28, 8 Aug 2024 (diff | hist) Fmoc chemistry 1,950 ±0 m add the reconstitution-stability sentence with its storage condition